CJC-1295
CJC-1295 with DAC (Drug Affinity Complex)
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate natural growth hormone production from the pituitary gland. Its unique Drug Affinity Complex (DAC) modification allows it to bind to albumin, extending its half-life to 6-8 days and enabling sustained pulsatile growth hormone release. Unlike direct growth hormone therapy, CJC-1295 works with the body's natural rhythms to optimize anabolic effects while maintaining physiological hormone patterns.
Daily Implementation Guide
Daily Implementation Schedule
Lifestyle Integration Strategies
Nutrition Optimization
- •High-protein meals (30-40g per meal)
- •Eat slowly to enhance satiety effects
- •Stay hydrated (3+ liters daily)
- •Avoid high-fat meals on injection day
Exercise Enhancement
- •Start with 150 min moderate exercise weekly
- •Resistance training 2-3x per week
- •Monitor energy levels during escalation
- •Adjust intensity based on side effects
Sleep & Recovery
- •Maintain consistent sleep schedule
- •Monitor for sleep quality improvements
- •Track energy levels throughout day
- •Adjust injection timing if affecting sleep
Progress Tracking
SUCCESS MILESTONES
Medical Disclaimer
CJC-1295 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings. Long-term effects are not well-studied in humans.